Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

IPCA Laboratories Limited (NSE: IPCALAB)

 
IPCALAB Technical Analysis
5
As on 23rd Apr 2024 IPCALAB SHARE Price closed @ 1323.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 994.22 & Strong Buy for SHORT-TERM with Stoploss of 1219.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IPCALABSHARE Price

Open 1335.90 Change Price %
High 1335.90 1 Day -5.00 -0.38
Low 1310.55 1 Week -17.55 -1.31
Close 1323.95 1 Month 127.90 10.69
Volume 260533 1 Year 483.30 57.49
52 Week High 1076.80 | 52 Week Low 675.00
 
IPCALAB CURRENT MONTH FUTURE
Close 1325.75
Contracts Traded 833300
Open Intrest 2142400
Change In O.I -16.68 %
Lot Size 650
IPCALAB CURRENT MONTH OPTION
Most Active Call 1350.00
Most Active put 1160.00
Highest O.I Buildup Call 1400.00
Highest O.I Buildup Put 1200.00
Expiry Date 2024-04-25
IPCALAB ALL MONTHS OPTIONS
For All IPCALAB Options Click Here
 
NSE INDIA Most Active Stocks
IDEA 14.40 11.63%
YESBANK 25.65 1.79%
SUZLON 41.85 2.45%
EASEMYTRIP 47.15 4.89%
RAMASTEEL 13.65 6.64%
TTML 84.90 9.27%
NHPC 89.75 1.36%
IRFC 147.75 2.53%
SAIL 152.25 2.59%
ZOMATO 187.45 -3.05%
 
NSE INDIA Top Gainers Stocks
SMARTLINK 212.70 20.00%
TEJASNET 1088.25 20.00%
OAL 383.55 19.99%
UMANGDAIRY 100.95 19.96%
ASHIMASYN 21.45 17.21%
LUXIND 1332.00 15.81%
SUDARSCHEM 717.05 13.87%
COCHINSHIP 1251.95 13.29%
INDRAMEDCO 276.25 12.66%
BSE 3199.85 12.22%
 
NSE INDIA Top Losers Stocks
ANUP 1827.25 -49.19%
ASTERDM 399.50 -22.18%
TEMBO 203.10 -10.76%
KMSUGAR 40.40 -9.92%
PALASHSECU 135.30 -9.77%
LYPSAGEMS 6.75 -6.25%
TPLPLASTEH 94.80 -5.77%
M&MFIN 263.45 -5.52%
SOLARA 547.60 -5.46%
KICL 4276.75 -5.23%
 
 
IPCALAB
Daily Charts		 IPCALAB
Intraday Charts		 Whats New @
Bazaartrend		 IPCALAB
Free Analysis
 
IPCALAB Important Levels Intraday
RESISTANCE1372.80
RESISTANCE1357.13
RESISTANCE1347.45
RESISTANCE1337.77
SUPPORT1310.13
SUPPORT1300.45
SUPPORT1290.77
SUPPORT1275.10
 
IPCALAB Target April 2024
Share
4th UP Target1584.04
3rd UP Target1458.65
2nd UP Target1381.14
1st UP Target1303.63
1st DOWN Target1082.47
2nd DOWN Target1004.96
3rd DOWN Target927.45
4th DOWN Target802.06
 
IPCALAB Weekly Target
4th UP Target1468.89
3rd UP Target1426.90
2nd UP Target1400.94
1st UP Target1374.98
1st DOWN Target1300.92
2nd DOWN Target1274.96
3rd DOWN Target1249.00
4th DOWN Target1207.01
 
IPCALAB Target2024
4th UP Target2061.33
3rd UP Target1757.24
2nd UP Target1569.28
1st UP Target1381.32
1st DOWN Target844.98
2nd DOWN Target657.02
3rd DOWN Target469.06
4th DOWN Target164.97
 
 
IPCALAB Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
 Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 44.05 Sideways
MFI (14) MFI is 38.99 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 1500.45
10 Day Avg Volume Traded -25.56 % Less then 10 Day Average Volume
 
IPCALAB Other Details
Segment EQ
Market Capital 278177841152.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
IPCALAB Address
IPCALAB
 
IPCALAB Latest News
 
Your Comments and Response on IPCA Laboratories Limited
 
IPCALAB Business Profile
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including cardiology, gastroenterology, dermatology, rheumatology, urology, ophthalmology, infectious disease, immunosuppressant, probiotics, respiratory, allergy, nutraceuticals, anti-neoplastic, malarial, neurology, psychiatry, orthopedics, helminthics, fever, hematology, hepatoprotective, diabetology, anti-epileptic, emollients/protectives, NSAIDs, rheumatology, anti-arthritic, and neuropathic pain, as well as products in various dosage forms comprising oral solids, powders for suspension, and liquid and dry injections. The company exports its products to approximately 100 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India. Address: 125, Kandivli Industrial Estate, Mumbai, India, 400067
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service